Listed

Iridex Corp

IRIXNasdaqCIK 1006045HealthcareFiscal year ends Jan 3

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$12.6m, Q2 FY2026
Operating income−$1.0m, Q2 FY2026
Net income−$1.3m, Q2 FY2026
Iridex Corp, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-30Q1 FY20242024-03-30Q2 FY20242024-06-29Q3 FY20242024-09-28Q4 FY20242024-12-28Q1 FY20252025-03-29Q2 FY20252025-06-28Q3 FY20252025-09-27Q4 FY20252026-01-03Q1 FY20262026-04-04Q2 FY20262026-07-04
Revenue$m12.9Revenue, Q3 FY2023, three months to 2023-09-30$12.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-12, accession 0000950170-24-125541.Report this figure12.5Revenue, Q4 FY2023, three months to 2023-12-30$12.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-27, accession 0000950170-25-046107. Derived: 12-month figure less the 9-month figure.Report this figure11.8Revenue, Q1 FY2024, three months to 2024-03-30$11.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-13, accession 0000950170-25-070469.Report this figure12.6Revenue, Q2 FY2024, three months to 2024-06-29$12.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-12, accession 0000950170-25-107375.Report this figure11.6Revenue, Q3 FY2024, three months to 2024-09-28$11.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001193125-25-277712.Report this figure12.7Revenue, Q4 FY2024, three months to 2024-12-28$12.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-04-02, accession 0001193125-26-140194. Derived: 12-month figure less the 9-month figure.Report this figure11.9Revenue, Q1 FY2025, three months to 2025-03-29$11.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-19, accession 0001193125-26-230789.Report this figure13.6Revenue, Q2 FY2025, three months to 2025-06-28$13.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-18, accession 0001193125-26-355641.Report this figure12.5Revenue, Q3 FY2025, three months to 2025-09-27$12.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001193125-25-277712.Report this figure14.7Revenue, Q4 FY2025, three months to 2026-01-03$14.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-04-02, accession 0001193125-26-140194. Derived: 12-month figure less the 9-month figure.Report this figure11.8Revenue, Q1 FY2026, three months to 2026-04-04$11.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-19, accession 0001193125-26-230789.Report this figure12.6Revenue, Q2 FY2026, three months to 2026-07-04$12.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-18, accession 0001193125-26-355641.Report this figure
Cost of revenue$m7.2Cost of revenue, Q3 FY2023, three months to 2023-09-30$7.2m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2024-11-12, accession 0000950170-24-125541.Report this figure7.6Cost of revenue, Q4 FY2023, three months to 2023-12-30$7.6m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2025-03-27, accession 0000950170-25-046107. Derived: 12-month figure less the 9-month figure.Report this figure7.3Cost of revenue, Q1 FY2024, three months to 2024-03-30$7.3m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-05-13, accession 0000950170-25-070469.Report this figure7.5Cost of revenue, Q2 FY2024, three months to 2024-06-29$7.5m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-08-12, accession 0000950170-25-107375.Report this figure7.3Cost of revenue, Q3 FY2024, three months to 2024-09-28$7.3m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-12, accession 0001193125-25-277712.Report this figure7.1Cost of revenue, Q4 FY2024, three months to 2024-12-28$7.1m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-04-02, accession 0001193125-26-140194. Derived: 12-month figure less the 9-month figure.Report this figure6.8Cost of revenue, Q1 FY2025, three months to 2025-03-29$6.8m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-19, accession 0001193125-26-230789.Report this figure8.9Cost of revenue, Q2 FY2025, three months to 2025-06-28$8.9m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-18, accession 0001193125-26-355641.Report this figure8.5Cost of revenue, Q3 FY2025, three months to 2025-09-27$8.5m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-12, accession 0001193125-25-277712.Report this figure9.2Cost of revenue, Q4 FY2025, three months to 2026-01-03$9.2m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-04-02, accession 0001193125-26-140194. Derived: 12-month figure less the 9-month figure.Report this figure7.1Cost of revenue, Q1 FY2026, three months to 2026-04-04$7.1m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-19, accession 0001193125-26-230789.Report this figure8.3Cost of revenue, Q2 FY2026, three months to 2026-07-04$8.3m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-18, accession 0001193125-26-355641.Report this figure
Gross profit$m5.6Gross profit, Q3 FY2023, three months to 2023-09-30$5.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-12, accession 0000950170-24-125541.Report this figure4.9Gross profit, Q4 FY2023, three months to 2023-12-30$4.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-27, accession 0000950170-25-046107. Derived: 12-month figure less the 9-month figure.Report this figure4.5Gross profit, Q1 FY2024, three months to 2024-03-30$4.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-13, accession 0000950170-25-070469.Report this figure5.1Gross profit, Q2 FY2024, three months to 2024-06-29$5.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-12, accession 0000950170-25-107375.Report this figure4.3Gross profit, Q3 FY2024, three months to 2024-09-28$4.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-12, accession 0001193125-25-277712.Report this figure5.6Gross profit, Q4 FY2024, three months to 2024-12-28$5.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-04-02, accession 0001193125-26-140194. Derived: 12-month figure less the 9-month figure.Report this figure5.1Gross profit, Q1 FY2025, three months to 2025-03-29$5.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-19, accession 0001193125-26-230789.Report this figure4.7Gross profit, Q2 FY2025, three months to 2025-06-28$4.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-18, accession 0001193125-26-355641.Report this figure4.0Gross profit, Q3 FY2025, three months to 2025-09-27$4.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-12, accession 0001193125-25-277712.Report this figure5.5Gross profit, Q4 FY2025, three months to 2026-01-03$5.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-04-02, accession 0001193125-26-140194. Derived: 12-month figure less the 9-month figure.Report this figure4.7Gross profit, Q1 FY2026, three months to 2026-04-04$4.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-19, accession 0001193125-26-230789.Report this figure4.3Gross profit, Q2 FY2026, three months to 2026-07-04$4.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-18, accession 0001193125-26-355641.Report this figure
Research and development$m1.5Research and development, Q3 FY2023, three months to 2023-09-30$1.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0000950170-24-125541.Report this figure1.7Research and development, Q4 FY2023, three months to 2023-12-30$1.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-27, accession 0000950170-25-046107. Derived: 12-month figure less the 9-month figure.Report this figure1.5Research and development, Q1 FY2024, three months to 2024-03-30$1.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-13, accession 0000950170-25-070469.Report this figure1.5Research and development, Q2 FY2024, three months to 2024-06-29$1.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0000950170-25-107375.Report this figure1.3Research and development, Q3 FY2024, three months to 2024-09-28$1.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001193125-25-277712.Report this figure1.1Research and development, Q4 FY2024, three months to 2024-12-28$1.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-04-02, accession 0001193125-26-140194. Derived: 12-month figure less the 9-month figure.Report this figure0.9Research and development, Q1 FY2025, three months to 2025-03-29$876.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-19, accession 0001193125-26-230789.Report this figure0.9Research and development, Q2 FY2025, three months to 2025-06-28$871.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-18, accession 0001193125-26-355641.Report this figure1.0Research and development, Q3 FY2025, three months to 2025-09-27$972.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001193125-25-277712.Report this figure0.9Research and development, Q4 FY2025, three months to 2026-01-03$949.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-04-02, accession 0001193125-26-140194. Derived: 12-month figure less the 9-month figure.Report this figure0.9Research and development, Q1 FY2026, three months to 2026-04-04$905.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-19, accession 0001193125-26-230789.Report this figure0.9Research and development, Q2 FY2026, three months to 2026-07-04$936.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-18, accession 0001193125-26-355641.Report this figure
Operating income$m(1.7)Operating income, Q3 FY2023, three months to 2023-09-30−$1.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-125541.Report this figure(3.1)Operating income, Q4 FY2023, three months to 2023-12-30−$3.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-27, accession 0000950170-25-046107. Derived: 12-month figure less the 9-month figure.Report this figure(3.3)Operating income, Q1 FY2024, three months to 2024-03-30−$3.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-13, accession 0000950170-25-070469.Report this figure(2.6)Operating income, Q2 FY2024, three months to 2024-06-29−$2.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0000950170-25-107375.Report this figure(1.9)Operating income, Q3 FY2024, three months to 2024-09-28−$1.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277712.Report this figure(0.5)Operating income, Q4 FY2024, three months to 2024-12-28−$502.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-04-02, accession 0001193125-26-140194. Derived: 12-month figure less the 9-month figure.Report this figure(0.2)Operating income, Q1 FY2025, three months to 2025-03-29−$205.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-19, accession 0001193125-26-230789.Report this figure(0.9)Operating income, Q2 FY2025, three months to 2025-06-28−$940.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-18, accession 0001193125-26-355641.Report this figure(1.4)Operating income, Q3 FY2025, three months to 2025-09-27−$1.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277712.Report this figure(0.0)Operating income, Q4 FY2025, three months to 2026-01-03−$15.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-04-02, accession 0001193125-26-140194. Derived: 12-month figure less the 9-month figure.Report this figure(0.3)Operating income, Q1 FY2026, three months to 2026-04-04−$324.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-19, accession 0001193125-26-230789.Report this figure(1.0)Operating income, Q2 FY2026, three months to 2026-07-04−$1.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-18, accession 0001193125-26-355641.Report this figure
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$8.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0000950170-24-125541.Report this figure0.1Income tax, Q4 FY2023, three months to 2023-12-30$60.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-27, accession 0000950170-25-046107. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-30$38.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-13, accession 0000950170-25-070469.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-29$19.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-12, accession 0000950170-25-107375.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-28$17.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001193125-25-277712.Report this figure(0.0)Income tax, Q4 FY2024, three months to 2024-12-28−$6.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-04-02, accession 0001193125-26-140194. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-29$12.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-19, accession 0001193125-26-230789.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-28$21.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-18, accession 0001193125-26-355641.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-27$4.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001193125-25-277712.Report this figure0.0Income tax, Q4 FY2025, three months to 2026-01-03$20.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-04-02, accession 0001193125-26-140194. Derived: 12-month figure less the 9-month figure.Report this figure0.1Income tax, Q1 FY2026, three months to 2026-04-04$58.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-19, accession 0001193125-26-230789.Report this figure0.1Income tax, Q2 FY2026, three months to 2026-07-04$70.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-18, accession 0001193125-26-355641.Report this figure
Net income$m(1.8)Net income, Q3 FY2023, three months to 2023-09-30−$1.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-125541.Report this figure(3.0)Net income, Q4 FY2023, three months to 2023-12-30−$3.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-27, accession 0000950170-25-046107. Derived: 12-month figure less the 9-month figure.Report this figure(3.5)Net income, Q1 FY2024, three months to 2024-03-30−$3.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-13, accession 0000950170-25-070469.Report this figure(2.7)Net income, Q2 FY2024, three months to 2024-06-29−$2.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-12, accession 0000950170-25-107375.Report this figure(1.9)Net income, Q3 FY2024, three months to 2024-09-28−$1.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277712.Report this figure(0.8)Net income, Q4 FY2024, three months to 2024-12-28−$834.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-04-02, accession 0001193125-26-140194. Derived: 12-month figure less the 9-month figure.Report this figure(1.7)Net income, Q1 FY2025, three months to 2025-03-29−$1.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-19, accession 0001193125-26-230789.Report this figure(1.0)Net income, Q2 FY2025, three months to 2025-06-28−$994.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-18, accession 0001193125-26-355641.Report this figure(1.6)Net income, Q3 FY2025, three months to 2025-09-27−$1.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277712.Report this figure(0.2)Net income, Q4 FY2025, three months to 2026-01-03−$184.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-04-02, accession 0001193125-26-140194. Derived: 12-month figure less the 9-month figure.Report this figure(0.5)Net income, Q1 FY2026, three months to 2026-04-04−$524.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-19, accession 0001193125-26-230789.Report this figure(1.3)Net income, Q2 FY2026, three months to 2026-07-04−$1.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-18, accession 0001193125-26-355641.Report this figure
Diluted EPS$ per share(0.11)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0000950170-24-125541.Report this figurenot reported(0.21)Diluted EPS, Q1 FY2024, three months to 2024-03-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-13, accession 0000950170-25-070469.Report this figure(0.16)Diluted EPS, Q2 FY2024, three months to 2024-06-29−$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-12, accession 0000950170-25-107375.Report this figure(0.12)Diluted EPS, Q3 FY2024, three months to 2024-09-28−$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001193125-25-277712.Report this figurenot reported(0.10)Diluted EPS, Q1 FY2025, three months to 2025-03-29−$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-19, accession 0001193125-26-230789.Report this figure(0.06)Diluted EPS, Q2 FY2025, three months to 2025-06-28−$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-18, accession 0001193125-26-355641.Report this figure(0.09)Diluted EPS, Q3 FY2025, three months to 2025-09-27−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001193125-25-277712.Report this figurenot reported(0.03)Diluted EPS, Q1 FY2026, three months to 2026-04-04−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-19, accession 0001193125-26-230789.Report this figure(0.07)Diluted EPS, Q2 FY2026, three months to 2026-07-04−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-18, accession 0001193125-26-355641.Report this figure
Basic EPS$ per share(0.11)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0000950170-24-125541.Report this figurenot reported(0.21)Basic EPS, Q1 FY2024, three months to 2024-03-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-13, accession 0000950170-25-070469.Report this figure(0.16)Basic EPS, Q2 FY2024, three months to 2024-06-29−$0.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0000950170-25-107375.Report this figure(0.12)Basic EPS, Q3 FY2024, three months to 2024-09-28−$0.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001193125-25-277712.Report this figurenot reported(0.10)Basic EPS, Q1 FY2025, three months to 2025-03-29−$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-19, accession 0001193125-26-230789.Report this figure(0.06)Basic EPS, Q2 FY2025, three months to 2025-06-28−$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-18, accession 0001193125-26-355641.Report this figure(0.09)Basic EPS, Q3 FY2025, three months to 2025-09-27−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001193125-25-277712.Report this figurenot reported(0.03)Basic EPS, Q1 FY2026, three months to 2026-04-04−$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-19, accession 0001193125-26-230789.Report this figure(0.07)Basic EPS, Q2 FY2026, three months to 2026-07-04−$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-18, accession 0001193125-26-355641.Report this figure

Balance sheet

Cash and equivalents$4.7m, Q2 FY2026
Long-term debt$1.0m, FY2024
Shareholders' equity$3.6m, Q2 FY2026
Iridex Corp, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-30Q1 FY20242024-03-30Q2 FY20242024-06-29Q3 FY20242024-09-28FY20242024-12-28Q1 FY20252025-03-29Q2 FY20252025-06-28Q3 FY20252025-09-27FY20252026-01-03Q1 FY20262026-04-04Q2 FY20262026-07-04
Cash and equivalents$m8.0Cash and equivalents, Q3 FY2023, at 2023-09-30$8.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-20, accession 0000950170-23-065162.Report this figure7.0Cash and equivalents, FY2023, at 2023-12-30$7.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-27, accession 0000950170-25-046107.Report this figure5.4Cash and equivalents, Q1 FY2024, at 2024-03-30$5.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-14, accession 0000950170-24-059771.Report this figure4.1Cash and equivalents, Q2 FY2024, at 2024-06-29$4.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0000950170-24-094090.Report this figure3.9Cash and equivalents, Q3 FY2024, at 2024-09-28$3.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0000950170-24-125541.Report this figure2.4Cash and equivalents, FY2024, at 2024-12-28$2.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-04-02, accession 0001193125-26-140194.Report this figure7.2Cash and equivalents, Q1 FY2025, at 2025-03-29$7.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-13, accession 0000950170-25-070469.Report this figure6.8Cash and equivalents, Q2 FY2025, at 2025-06-28$6.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0000950170-25-107375.Report this figure5.6Cash and equivalents, Q3 FY2025, at 2025-09-27$5.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001193125-25-277712.Report this figure6.0Cash and equivalents, FY2025, at 2026-01-03$6.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-18, accession 0001193125-26-355641.Report this figure4.6Cash and equivalents, Q1 FY2026, at 2026-04-04$4.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-19, accession 0001193125-26-230789.Report this figure4.7Cash and equivalents, Q2 FY2026, at 2026-07-04$4.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-18, accession 0001193125-26-355641.Report this figure
Current assets$m27.3Current assets, Q3 FY2023, at 2023-09-30$27.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-20, accession 0000950170-23-065162.Report this figure27.5Current assets, FY2023, at 2023-12-30$27.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-27, accession 0000950170-25-046107.Report this figure27.6Current assets, Q1 FY2024, at 2024-03-30$27.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0000950170-24-059771.Report this figure25.0Current assets, Q2 FY2024, at 2024-06-29$25.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-094090.Report this figure24.3Current assets, Q3 FY2024, at 2024-09-28$24.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-125541.Report this figure23.6Current assets, FY2024, at 2024-12-28$23.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-04-02, accession 0001193125-26-140194.Report this figure29.1Current assets, Q1 FY2025, at 2025-03-29$29.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-13, accession 0000950170-25-070469.Report this figure26.9Current assets, Q2 FY2025, at 2025-06-28$26.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0000950170-25-107375.Report this figure24.1Current assets, Q3 FY2025, at 2025-09-27$24.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001193125-25-277712.Report this figure25.3Current assets, FY2025, at 2026-01-03$25.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-18, accession 0001193125-26-355641.Report this figure24.6Current assets, Q1 FY2026, at 2026-04-04$24.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-19, accession 0001193125-26-230789.Report this figure24.0Current assets, Q2 FY2026, at 2026-07-04$24.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-18, accession 0001193125-26-355641.Report this figure
Total assets$m34.9Total assets, Q3 FY2023, at 2023-09-30$34.9m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-20, accession 0000950170-23-065162.Report this figure34.4Total assets, FY2023, at 2023-12-30$34.4m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-27, accession 0000950170-25-046107.Report this figure34.1Total assets, Q1 FY2024, at 2024-03-30$34.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0000950170-24-059771.Report this figure31.2Total assets, Q2 FY2024, at 2024-06-29$31.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0000950170-24-094090.Report this figure30.2Total assets, Q3 FY2024, at 2024-09-28$30.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0000950170-24-125541.Report this figure29.1Total assets, FY2024, at 2024-12-28$29.1m. XBRL concept us-gaap:Assets. 10-K filed 2026-04-02, accession 0001193125-26-140194.Report this figure34.2Total assets, Q1 FY2025, at 2025-03-29$34.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-13, accession 0000950170-25-070469.Report this figure31.6Total assets, Q2 FY2025, at 2025-06-28$31.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0000950170-25-107375.Report this figure28.4Total assets, Q3 FY2025, at 2025-09-27$28.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001193125-25-277712.Report this figure29.2Total assets, FY2025, at 2026-01-03$29.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-18, accession 0001193125-26-355641.Report this figure28.3Total assets, Q1 FY2026, at 2026-04-04$28.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-19, accession 0001193125-26-230789.Report this figure27.3Total assets, Q2 FY2026, at 2026-07-04$27.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-18, accession 0001193125-26-355641.Report this figure
Current liabilities$m10.3Current liabilities, Q3 FY2023, at 2023-09-30$10.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-20, accession 0000950170-23-065162.Report this figure13.0Current liabilities, FY2023, at 2023-12-30$13.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-27, accession 0000950170-25-046107.Report this figure16.1Current liabilities, Q1 FY2024, at 2024-03-30$16.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0000950170-24-059771.Report this figure16.1Current liabilities, Q2 FY2024, at 2024-06-29$16.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0000950170-24-094090.Report this figure15.9Current liabilities, Q3 FY2024, at 2024-09-28$15.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-125541.Report this figure16.6Current liabilities, FY2024, at 2024-12-28$16.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-04-02, accession 0001193125-26-140194.Report this figure14.9Current liabilities, Q1 FY2025, at 2025-03-29$14.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-13, accession 0000950170-25-070469.Report this figure13.7Current liabilities, Q2 FY2025, at 2025-06-28$13.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0000950170-25-107375.Report this figure12.4Current liabilities, Q3 FY2025, at 2025-09-27$12.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001193125-25-277712.Report this figure13.2Current liabilities, FY2025, at 2026-01-03$13.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-18, accession 0001193125-26-355641.Report this figure12.8Current liabilities, Q1 FY2026, at 2026-04-04$12.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-19, accession 0001193125-26-230789.Report this figure13.2Current liabilities, Q2 FY2026, at 2026-07-04$13.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-18, accession 0001193125-26-355641.Report this figure
Total liabilities$m22.9Total liabilities, Q3 FY2023, at 2023-09-30$22.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-20, accession 0000950170-23-065162.Report this figure24.9Total liabilities, FY2023, at 2023-12-30$24.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-27, accession 0000950170-25-046107.Report this figure27.6Total liabilities, Q1 FY2024, at 2024-03-30$27.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0000950170-24-059771.Report this figure27.0Total liabilities, Q2 FY2024, at 2024-06-29$27.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0000950170-24-094090.Report this figure27.5Total liabilities, Q3 FY2024, at 2024-09-28$27.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0000950170-24-125541.Report this figure27.0Total liabilities, FY2024, at 2024-12-28$27.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-04-02, accession 0001193125-26-140194.Report this figure27.4Total liabilities, Q1 FY2025, at 2025-03-29$27.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-13, accession 0000950170-25-070469.Report this figure25.5Total liabilities, Q2 FY2025, at 2025-06-28$25.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0000950170-25-107375.Report this figure23.7Total liabilities, Q3 FY2025, at 2025-09-27$23.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001193125-25-277712.Report this figure24.2Total liabilities, FY2025, at 2026-01-03$24.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-18, accession 0001193125-26-355641.Report this figure23.5Total liabilities, Q1 FY2026, at 2026-04-04$23.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-19, accession 0001193125-26-230789.Report this figure23.6Total liabilities, Q2 FY2026, at 2026-07-04$23.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-18, accession 0001193125-26-355641.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reported1.4Long-term debt, Q3 FY2024, at 2024-09-28$1.4m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-11-12, accession 0000950170-24-125541.Report this figure1.0Long-term debt, FY2024, at 2024-12-28$1.0m. XBRL concept us-gaap:LongTermDebt. 10-K filed 2026-04-02, accession 0001193125-26-140194.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Short-term borrowings$mnot reportednot reportednot reportednot reported1.3Short-term borrowings, Q3 FY2024, at 2024-09-28$1.3m. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2024-11-12, accession 0000950170-24-125541.Report this figure1.7Short-term borrowings, FY2024, at 2024-12-28$1.7m. XBRL concept us-gaap:ShortTermBorrowings. 10-K filed 2026-04-02, accession 0001193125-26-140194.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m12.1Shareholders' equity, Q3 FY2023, at 2023-09-30$12.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0000950170-24-125541.Report this figure9.5Shareholders' equity, FY2023, at 2023-12-30$9.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-04-02, accession 0001193125-26-140194.Report this figure6.5Shareholders' equity, Q1 FY2024, at 2024-03-30$6.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-12, accession 0000950170-25-107375.Report this figure4.2Shareholders' equity, Q2 FY2024, at 2024-06-29$4.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-277712.Report this figure2.6Shareholders' equity, Q3 FY2024, at 2024-09-28$2.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-277712.Report this figure2.1Shareholders' equity, FY2024, at 2024-12-28$2.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-18, accession 0001193125-26-355641.Report this figure0.9Shareholders' equity, Q1 FY2025, at 2025-03-29$852.0k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-18, accession 0001193125-26-355641.Report this figure6.1Shareholders' equity, Q2 FY2025, at 2025-06-28$6.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-18, accession 0001193125-26-355641.Report this figure4.7Shareholders' equity, Q3 FY2025, at 2025-09-27$4.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-277712.Report this figure4.9Shareholders' equity, FY2025, at 2026-01-03$4.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-18, accession 0001193125-26-355641.Report this figure4.7Shareholders' equity, Q1 FY2026, at 2026-04-04$4.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-18, accession 0001193125-26-355641.Report this figure3.6Shareholders' equity, Q2 FY2026, at 2026-07-04$3.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-18, accession 0001193125-26-355641.Report this figure

Cash flow

Operating cash flow$174.0k, Q2 FY2026
Capital expenditure$50.0k, Q2 FY2026
Iridex Corp, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-30Q1 FY20242024-03-30Q2 FY20242024-06-29Q3 FY20242024-09-28Q4 FY20242024-12-28Q1 FY20252025-03-29Q2 FY20252025-06-28Q3 FY20252025-09-27Q4 FY20252026-01-03Q1 FY20262026-04-04Q2 FY20262026-07-04
Operating cash flow$k(1,782)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$1.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0000950170-24-125541. Derived: 9-month figure less the 6-month figure.Report this figure(979)Operating cash flow, Q4 FY2023, three months to 2023-12-30−$979.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-27, accession 0000950170-25-046107. Derived: 12-month figure less the 9-month figure.Report this figure(1,648)Operating cash flow, Q1 FY2024, three months to 2024-03-30−$1.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-13, accession 0000950170-25-070469.Report this figure(1,326)Operating cash flow, Q2 FY2024, three months to 2024-06-29−$1.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0000950170-25-107375. Derived: 6-month figure less the 3-month figure.Report this figure(3,073)Operating cash flow, Q3 FY2024, three months to 2024-09-28−$3.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001193125-25-277712. Derived: 9-month figure less the 6-month figure.Report this figure(1,238)Operating cash flow, Q4 FY2024, three months to 2024-12-28−$1.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-04-02, accession 0001193125-26-140194. Derived: 12-month figure less the 9-month figure.Report this figure(1,149)Operating cash flow, Q1 FY2025, three months to 2025-03-29−$1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-19, accession 0001193125-26-230789.Report this figure(397)Operating cash flow, Q2 FY2025, three months to 2025-06-28−$397.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-18, accession 0001193125-26-355641. Derived: 6-month figure less the 3-month figure.Report this figure(1,158)Operating cash flow, Q3 FY2025, three months to 2025-09-27−$1.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001193125-25-277712. Derived: 9-month figure less the 6-month figure.Report this figure589Operating cash flow, Q4 FY2025, three months to 2026-01-03$589.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-04-02, accession 0001193125-26-140194. Derived: 12-month figure less the 9-month figure.Report this figure(1,335)Operating cash flow, Q1 FY2026, three months to 2026-04-04−$1.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-19, accession 0001193125-26-230789.Report this figure174Operating cash flow, Q2 FY2026, three months to 2026-07-04$174.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-18, accession 0001193125-26-355641. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$k82.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$82.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0000950170-24-125541. Derived: 9-month figure less the 6-month figure.Report this figure(32.0)Capital expenditure, Q4 FY2023, three months to 2023-12-30−$32.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-27, accession 0000950170-25-046107. Derived: 12-month figure less the 9-month figure.Report this figure3.0Capital expenditure, Q1 FY2024, three months to 2024-03-30$3.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-13, accession 0000950170-25-070469.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-29$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-12, accession 0000950170-25-107375. Derived: 6-month figure less the 3-month figure.Report this figure1.0Capital expenditure, Q3 FY2024, three months to 2024-09-28$1.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001193125-25-277712. Derived: 9-month figure less the 6-month figure.Report this figure9.0Capital expenditure, Q4 FY2024, three months to 2024-12-28$9.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-04-02, accession 0001193125-26-140194. Derived: 12-month figure less the 9-month figure.Report this figure11.0Capital expenditure, Q1 FY2025, three months to 2025-03-29$11.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-19, accession 0001193125-26-230789.Report this figure13.0Capital expenditure, Q2 FY2025, three months to 2025-06-28$13.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-18, accession 0001193125-26-355641. Derived: 6-month figure less the 3-month figure.Report this figure13.0Capital expenditure, Q3 FY2025, three months to 2025-09-27$13.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001193125-25-277712. Derived: 9-month figure less the 6-month figure.Report this figure106Capital expenditure, Q4 FY2025, three months to 2026-01-03$106.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-04-02, accession 0001193125-26-140194. Derived: 12-month figure less the 9-month figure.Report this figure101Capital expenditure, Q1 FY2026, three months to 2026-04-04$101.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-19, accession 0001193125-26-230789.Report this figure50.0Capital expenditure, Q2 FY2026, three months to 2026-07-04$50.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-18, accession 0001193125-26-355641. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)17.42m, Q2 FY2026
Iridex Corp, shares, quarterly
Line itemUnitQ3 FY20222022-10-01Q1 FY20232023-04-01Q2 FY20232023-07-01Q3 FY20232023-09-30Q1 FY20242024-03-30Q2 FY20242024-06-29Q3 FY20242024-09-28Q1 FY20252025-03-29Q2 FY20252025-06-28Q3 FY20252025-09-27Q1 FY20262026-04-04Q2 FY20262026-07-04
Diluted shares (weighted)m shares16.0Diluted shares (weighted), Q3 FY2022, three months to 2022-10-0115,986,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-20, accession 0000950170-23-065162.Report this figure16.0Diluted shares (weighted), Q1 FY2023, three months to 2023-04-0116,001,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-14, accession 0000950170-24-059771.Report this figure16.0Diluted shares (weighted), Q2 FY2023, three months to 2023-07-0116,036,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0000950170-24-094090.Report this figure16.2Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3016,231,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0000950170-24-125541.Report this figure16.3Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3016,253,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-13, accession 0000950170-25-070469.Report this figure16.3Diluted shares (weighted), Q2 FY2024, three months to 2024-06-2916,287,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-12, accession 0000950170-25-107375.Report this figure16.6Diluted shares (weighted), Q3 FY2024, three months to 2024-09-2816,581,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001193125-25-277712.Report this figure16.7Diluted shares (weighted), Q1 FY2025, three months to 2025-03-2916,727,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-19, accession 0001193125-26-230789.Report this figure16.8Diluted shares (weighted), Q2 FY2025, three months to 2025-06-2816,793,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-18, accession 0001193125-26-355641.Report this figure17.0Diluted shares (weighted), Q3 FY2025, three months to 2025-09-2717,009,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001193125-25-277712.Report this figure17.3Diluted shares (weighted), Q1 FY2026, three months to 2026-04-0417,311,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-19, accession 0001193125-26-230789.Report this figure17.4Diluted shares (weighted), Q2 FY2026, three months to 2026-07-0417,418,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-18, accession 0001193125-26-355641.Report this figure

Shares outstanding: 17.56mShares outstanding, period not labelled, at 2026-08-1317,564,912 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-18, accession 0001193125-26-355641.Report this figure at Aug 13, 2026, from the cover of the 10-Q filed Aug 18, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. Listed shows no prices and gives no investment advice.